We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

50 hedge funds and large institutions have $30.8M invested in Applied Genetic Technologies Corporation in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

11,933% more call options, than puts

Call options by funds: $722K | Put options by funds: $6K

58% more capital invested

Capital invested by funds: $19.5M → $30.8M (+$11.2M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 5450 (-4)

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

52% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 21

Holders
50
Holders Change
-4
Holders Change %
-7.41%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
10
Reduced
21
Closed
10
Calls
$722K
Puts
$6K
Net Calls
+$716K
Net Calls Change
+$544K
Name Holding Trade Value Shares
Change
Change in
Stake
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
$110K
Morgan Stanley
27
Morgan Stanley
New York
$101K -$43K -12,302 -34%
Northern Trust
28
Northern Trust
Illinois
$87K
UBS Group
29
UBS Group
Switzerland
$84K -$6.2K -1,775 -8%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$75K
Squarepoint
31
Squarepoint
New York
$60K +$50.4K +14,428 New
ARTA
32
A.R.T. Advisors
New York
$55K -$49.1K -14,037 -52%
PAM
33
Panagora Asset Management
Massachusetts
$47K -$229K -65,625 -85%
SEI Investments
34
SEI Investments
Pennsylvania
$47K +$39K +11,151 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$45K -$1.17K -334 -3%
Ameriprise
36
Ameriprise
Minnesota
$42K
TRCT
37
Tower Research Capital (TRC)
New York
$33K +$1.1K +314 +4%
FCMT
38
Founders Capital Management (Texas)
Texas
$15K
JP Morgan Chase
39
JP Morgan Chase
New York
$13K -$10.3K -2,945 -48%
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
$8K -$28 -8 -0.4%
Federated Hermes
41
Federated Hermes
Pennsylvania
$7K
Simplex Trading
42
Simplex Trading
Illinois
$6K +$1.8K +516 +48%
MAM
43
Meeder Asset Management
Ohio
$3K +$853 +244 +61%
NFG
44
Next Financial Group
Texas
$2K
LTFS
45
Ladenburg Thalmann Financial Services
Florida
$2K +$1.44K +412 New
NFH
46
NEXT Financial Holdings
Texas
$2K +$1.57K +450 New
Deutsche Bank
47
Deutsche Bank
Germany
$1K -$178K -50,873 -99%
Fidelity Investments
48
Fidelity Investments
Massachusetts
$1K -$374 -107 -30%
BNP Paribas Financial Markets
49
BNP Paribas Financial Markets
France
$13 -$1.73K -496 -99%
AL
50
AJO LP
Pennsylvania
-$601K -241,458 Closed

AGTC Hedge Fund Activity: Q1 2019 in Review

50 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2019, worth a combined $30.8M — up 58% from $19.5M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AGTC and 6 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 10 added.

The largest buyer was Altrinsic Global Advisors, adding an estimated $210K. The largest seller was AJO LP, exiting entirely with an estimated $601K sold.

  • 50 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2019, down from 54 in Q4 2018.
  • Funds reported $30.8M of Applied Genetic Technologies Corporation stock for Q1 2019, up 58% quarter-over-quarter.
  • 6 funds opened new Applied Genetic Technologies Corporation positions in Q1 2019 and 10 closed out, a net change of -4 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q1 2019 was Altrinsic Global Advisors, an estimated $210K added.
  • The largest Applied Genetic Technologies Corporation seller in Q1 2019 was AJO LP, an estimated $601K sold.

Based on aggregated 13F filings for Q1 2019.